Schreiner MediPharm film blinds blister packs

Published: 4-Jul-2011
Packaging Regulatory

Film is printed with special ink that makes it impervious to light

German packaging specialist Schreiner MediPharm has developed a special film that easily and reliably neutralises blister packs used in clinical drug trials. Hospital staff and patients are thus unable to tell whether the trial drug or a placebo is being administered and are not influenced by the external appearance of the drug’s packaging during the trial.

For efficient blinding of the blister the label must opaquely cover the pack but at the same time the film must be thin enough to allow the pills to be extracted without the exertion of additional force.

The blinding film is printed with special ink that makes the label impervious to light. Due to the specific properties of the material, the film is destroyed if an attempt is made to peel it off.

The material can be used on blister packs of various sizes and exhibits the same properties irrespective of the configuration of the individual cavities.

  • Companies:
  • Schreiner MediPharm
See more

You may also like

Packaging

Smart RFID labels from Schreiner MediPharm: safety and efficiency in the healthcare sector

Read more
The Robust RFID labels from Schreiner MediPharm enable the precise tracking of drugs, reduce medication errors and enhance supply efficiency

Trending Articles

  1. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste
  2. ProMach Pharma presents new equipment at Pack Expo Las Vegas Several new systems will be on exhibit for the first time, alongside other advanced processing and packaging equipment for pharmaceuticals, biopharmaceuticals, nutraceuticals, medical devices and more
  3. Balancing innovation and accessibility in amino acid testing Butterworth Laboratories expands analytical capabilities to support compliance with Ph. Eur. standards
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Quality management during manufacturing changes: part I Change is a universal constant and continues to accelerate in the realms of pharmaceutical, medical device and in-vitro diagnostic manufacturers who face ever-increasing pressure to optimise costs while maintaining high product quality and patient safety standards
  5. NICE recommends enfortumab vedotin with KEYTRUDA for adults in England/Wales with untreated metastatic urothelial cancer The results from the Phase III study EV-302/KN-A39 showed nearly a doubling of survival rates in patients compared with those who received platinum-based chemotherapy, which is the current standard of care in the UK

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Packaging

Smart RFID labels from Schreiner MediPharm: safety and efficiency in the healthcare sector

The Robust RFID labels from Schreiner MediPharm enable the precise tracking of drugs, reduce medication errors and enhance supply efficiency
Packaging

FINAT award recognises pioneering product in “Innovation” category

At this year’s FINAT Label Competition, Schreiner Group impressed with its Smart Syringe Box from the Schreiner MediPharm business unit
Packaging

Schreiner MediPharm debuts new digital labels for clinical trials

The technology has the potential to replace conventional labels by electronic ones with digital displays in the future
Packaging

Innovative light protection labels for prefilled syringes showcased at Pharmapack 2025

Schreiner MediPharm presents new functional labels for light-sensitive substance
Packaging

Schreiner MediPharm develops protective label for light-sensitive ADC on behalf of WuXi XDC

The pharmaceutical labelling company developed a cover for a light/UV-sensitive ADC drug product contained in a vial on behalf of CRDMO WuXi
Packaging

Schreiner MediPharm to present novel RFID-Labels with digital seal function at CPHI 2024

Schreiner MediPharm, a leading developer and manufacturer of innovative functional labels for the healthcare industry, will be presenting a new RFID-Label with digital first-opening indication at CPHI in Milan
Manufacturing

Schreiner MediPharm to present its product innovations at CPHI China

Focus on sustainability and novel active ingredients with Freeze-Light-Protect and Needle-Trap solutions
Subscribe now